These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21098137)

  • 1. Detection and elimination of interference by the heterophilic antibody in antibody microarray-based immunoassay.
    Yang X; Ji H; Lin X; Han Z; Liu F; Zhong R
    Clin Chem; 2011 Mar; 57(3):527-9. PubMed ID: 21098137
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of heterophilic antibody interference in eight automated tumor marker immunoassays.
    Preissner CM; Dodge LA; O'Kane DJ; Singh RJ; Grebe SK
    Clin Chem; 2005 Jan; 51(1):208-10. PubMed ID: 15613712
    [No Abstract]   [Full Text] [Related]  

  • 3. Eliminating heterophilic antibody interference for ferritin detection using Olympus F(ab')2 based reagent.
    Grouzmann E; Dayer N; Bain C; Neville CM; McCusker MD; Wang RY
    Clin Lab; 2008; 54(9-10):355-7. PubMed ID: 19097493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterophilic antibody interference in immunometric assays.
    Bolstad N; Warren DJ; Nustad K
    Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):647-61. PubMed ID: 24094636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference of circulating endogenous antibodies on the Dimension® DGNA digoxin immunoassay: elimination with a heterophilic blocking reagent.
    Hermida-Cadahía EF; Calvo MM; Tutor JC
    Clin Biochem; 2010 Dec; 43(18):1475-7. PubMed ID: 20875811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera.
    Bolstad N; Warren DJ; Bjerner J; Kravdal G; Schwettmann L; Olsen KH; Rustad P; Nustad K
    Clin Chem Lab Med; 2011 Sep; 49(12):2001-6. PubMed ID: 21899496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterophilic antibodies remain a problem for the immunoassay laboratory.
    Ward G; McKinnon L; Badrick T; Hickman PE
    Am J Clin Pathol; 1997 Oct; 108(4):417-21. PubMed ID: 9322595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The war on heterophilic antibody interference.
    Bjerner J; Børmer OP; Nustad K
    Clin Chem; 2005 Jan; 51(1):9-11. PubMed ID: 15613705
    [No Abstract]   [Full Text] [Related]  

  • 9. Human heterophilic antibodies display specificity for murine IgG subclasses.
    Bjerner J; Olsen KH; Børmer OP; Nustad K
    Clin Biochem; 2005 May; 38(5):465-72. PubMed ID: 15820778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference from heterophilic antibodies in TSH assays.
    Halsall DJ; English E; Chatterjee VK
    Ann Clin Biochem; 2009 Jul; 46(Pt 4):345-6. PubMed ID: 19487413
    [No Abstract]   [Full Text] [Related]  

  • 11. Reducing heterophilic antibody interference in immunoassays using single-chain antibodies.
    Baird CL; Tan R; Fischer CJ; Victry KD; Zangar RC; Rodland KD
    Anal Biochem; 2011 Dec; 419(2):333-5. PubMed ID: 21933659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody multispecificity in immunoassay interference.
    Levinson SS
    Clin Biochem; 1992 Apr; 25(2):77-87. PubMed ID: 1623581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The significance of the tissue microarray technique].
    Wollenberg B
    HNO; 2004 May; 52(5):394. PubMed ID: 15054585
    [No Abstract]   [Full Text] [Related]  

  • 14. Heterophilic antibodies: a problem for all immunoassays.
    Boscato LM; Stuart MC
    Clin Chem; 1988 Jan; 34(1):27-33. PubMed ID: 3338181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterophilic antibody interference in a chemiluminescent immunometric erythropoietin assay.
    Spruill L; Constantin MA; Andrews DM; Zhu Y
    Clin Chim Acta; 2010 Aug; 411(15-16):1156-7. PubMed ID: 20416289
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for interference in immunoassays.
    Span PN; Grebenchtchikov N; Geurts-Moespot J; Sweep CG
    Clin Chem; 2003 Oct; 49(10):1708-9. PubMed ID: 14500605
    [No Abstract]   [Full Text] [Related]  

  • 17. Taguchi design-based optimization of sandwich immunoassay microarrays for detecting breast cancer biomarkers.
    Luo W; Pla-Roca M; Juncker D
    Anal Chem; 2011 Jul; 83(14):5767-74. PubMed ID: 21667934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of photonic crystal enhanced fluorescence to cancer biomarker microarrays.
    Huang CS; George S; Lu M; Chaudhery V; Tan R; Zangar RC; Cunningham BT
    Anal Chem; 2011 Feb; 83(4):1425-30. PubMed ID: 21250635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eliminating interference from heterophilic antibodies in a two-site immunoassay for creatine kinase MB by using F(ab')2 conjugate and polyclonal mouse IgG.
    Vaidya HC; Beatty BG
    Clin Chem; 1992 Sep; 38(9):1737-42. PubMed ID: 1526006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole blood levels evaluation measuring tacrolimus by ACMIA method on washed erythrocytes in a liver transplant recipient with circulating heterophilic antibodies.
    Tempestilli M; Comandini UV; Vennarecci G; Pucillo LP
    Clin Chim Acta; 2011 Jul; 412(15-16):1480-1. PubMed ID: 21473862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.